Cite
Once vs twice-daily abacavir and lamivudine in African children
MLA
AS Walker, et al. “Once vs Twice-Daily Abacavir and Lamivudine in African Children.” AIDS, vol. 30, July 2016, pp. 1761–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ad7b63e2178eb753332ca0008f8e9c60&authtype=sso&custid=ns315887.
APA
AS Walker, Margaret J. Thomason, Moira J. Spyer, Adrian Cook, Patricia Nahirya-Ntege, Immaculate Nankya, Lincoln Mugarura, Diana M. Gibb, Bethany Naidoo-James, Emmanuel Ndashimye, Navdeep K. Thoofer, Victor Musiime, Tawanda Mhute, Marshall Munjoma, Wendy Snowden, & Philip Kasirye. (2016). Once vs twice-daily abacavir and lamivudine in African children. AIDS, 30, 1761–1770.
Chicago
AS Walker, Margaret J. Thomason, Moira J. Spyer, Adrian Cook, Patricia Nahirya-Ntege, Immaculate Nankya, Lincoln Mugarura, et al. 2016. “Once vs Twice-Daily Abacavir and Lamivudine in African Children.” AIDS 30 (July): 1761–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ad7b63e2178eb753332ca0008f8e9c60&authtype=sso&custid=ns315887.